Ardelyx logo

Director, Medical Writing

Ardelyx

Newark, CA; San Francisco, CAOnsitePosted 1 day ago$220,000 - $270,000/year
Full TimeDirector & AboveMedical AffairsPharmaceutical
Original posting ↗

Summary

Ardelyx is seeking a Director, Medical Writing to establish and lead its in-house medical writing capability. As the company's first internal medical writer, this role will be responsible for developing high-quality clinical and regulatory documents while building the processes, standards, and external partnerships needed to support the organization's growing research and development activities. The Director will partner closely with Clinical Development, Regulatory Affairs, Biometrics, Clinical Operations, and Drug Safety to translate complex scientific and clinical information into clear, accurate, and submission-ready documents.

Job description

Position Summary

Ardelyx is seeking a Director, Medical Writing to establish and lead its in-house medical writing capability. As the company's first internal medical writer, this role will be responsible for developing high-quality clinical and regulatory documents while building the processes, standards, and external partnerships needed to support the organization's growing research and development activities. The Director will partner closely with Clinical Development, Regulatory Affairs, Biometrics, Clinical Operations, and Drug Safety to translate complex scientific and clinical information into clear, accurate, and submission-ready documents.

Responsibilities

  • Plan, author, and oversee the development and delivery of clinical and regulatory documents, including clinical study protocols and amendments, clinical study reports, investigator's brochures, and clinical summaries and overviews
  • Author key sections of supplemental New Drug Applications (sNDAs), label updates, and other regulatory submissions, and coordinate content across contributing functions
  • Define the medical writing operating model and roadmap, including which activities to bring in-house and where external support remains appropriate
  • Direct and oversee external medical writers and vendors, including managing scope, timelines, budget, document quality, and knowledge transfer
  • Partner with clinical and scientific leaders to develop clear document strategies, interpret study findings, and ensure consistent scientific messaging
  • Drive cross-functional document development and review, consolidating feedback, resolving conflicting comments, and ensuring timely delivery of high-quality documents
  • Develop standardized templates, style guides, review practices, and quality standards to improve consistency and efficiency
  • Evaluate AI-enabled tools and approaches that improve writing productivity while protecting confidential information and maintaining scientific accuracy

Qualifications

  • Bachelor's degree, advanced degree preferred, in life sciences or a related discipline with 10+ years of relevant medical writing experience in biotech or pharmaceutical industry
  • Demonstrated experience leading medical writing deliverables for Phase 2 and Phase 3 clinical studies and serving as the lead writer for at least one NDA, sNDA, or comparable regulatory submission
  • Strong understanding of clinical development, study design, and the interpretation and presentation of clinical and statistical results
  • Working knowledge of relevant regulatory guidance and document standards, including ICH guidance (e.g., E3, M11, E6(R3)) and electronic Common Technical Document conventions
  • Exceptional written and verbal communication skills
  • Proven ability to lead cross-functional document reviews, reconcile differing perspectives, and influence colleagues without direct authority
  • Experience selecting and overseeing external medical writers or vendors
  • Ability to work independently in a hands-on capacity, manage competing priorities, and deliver high-quality work in a lean, evolving organization
  • Experience establishing or improving medical writing processes, including developing functional capabilities, templates, and standards
  • Gastrointestinal or nephrology therapeutic experience is a plus
  • Ability to travel up to 15% (applies only to remote candidates)

Requirements

  • Bachelor's degree in life sciences or a related discipline
  • 10+ years of relevant medical writing experience in biotech or pharmaceutical industry
  • Experience leading medical writing deliverables for Phase 2 and Phase 3 clinical studies
  • Lead writer for at least one NDA, sNDA, or comparable regulatory submission
  • Strong understanding of clinical development, study design, and interpretation of clinical and statistical results
  • Working knowledge of ICH guidance (E3, M11, E6(R3)) and eCTD conventions
  • Exceptional written and verbal communication skills
  • Proven ability to lead cross-functional document reviews and influence colleagues without direct authority
  • Experience selecting and overseeing external medical writers or vendors
  • Ability to work independently and manage competing priorities
  • Experience establishing or improving medical writing processes, templates, and standards
  • Gastrointestinal or nephrology therapeutic experience is a plus
  • Ability to travel up to 15%

Benefits

  • 401(k) Matching
  • Paid Parental Leave
  • Organ & Bone Marrow Leave
  • Equity Incentive Plans
  • Medical, Dental & Vision
  • Life & Disability Insurance
  • Flexible Time Off
  • Winter Holiday Shutdown
  • Paid Holidays

Company overview

Ardelyx, Inc. is a biopharmaceutical company founded in 2007 and headquartered in Fremont, California, with additional offices in Waltham, Massachusetts. The company specializes in discovering, developing, and commercializing innovative, first-in-class medicines that address significant unmet medical needs. Ardelyx has developed a unique platform that enables the discovery of novel biological mechanisms and pathways to create potent and efficacious therapies while minimizing side effects and drug-drug interactions commonly associated with traditional systemically absorbed medicines. The company currently has two FDA-approved commercial products: IBSRELA® (tenapanor) for the treatment of adults with irritable bowel syndrome with constipation (IBS-C), and XPHOZAH® (tenapanor) for reducing serum phosphorus in adults with chronic kidney disease on dialysis. Ardelyx has established strategic partnerships for international commercialization, including agreements with Kyowa Kirin in Japan and Fosun Pharma in China. As a publicly traded company on NASDAQ under the symbol ARDX, Ardelyx employs approximately 201-500 professionals and continues to advance its pipeline of gastrointestinal and renal disease therapeutics.

Explore more jobs of your matchFind more biopharma roles with GetBioJob.